What is the official website of CHANGE BIOTEC LIMITED ?

The official website of CHANGE BIOTEC LIMITED is www.changebiotec.com.

What is CHANGE BIOTEC LIMITED's cybersecurity risk score?

CHANGE BIOTEC LIMITED has an AI-generated cybersecurity risk score of 749 out of 1000, indicating a Moderate security posture according to Rankiteo's assessment.

How many security incidents has CHANGE BIOTEC LIMITED experienced?

According to Rankiteo, CHANGE BIOTEC LIMITED currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has CHANGE BIOTEC LIMITED been affected by any supply chain cyber incidents ?

According to Rankiteo, CHANGE BIOTEC LIMITED has not been affected by any supply chain cyber incidents, and no incident IDs are currently listed for the organization.

Does CHANGE BIOTEC LIMITED have SOC 2 Type 1 certification ?

According to Rankiteo, CHANGE BIOTEC LIMITED is not certified under SOC 2 Type 1.

Does CHANGE BIOTEC LIMITED have SOC 2 Type 2 certification ?

According to Rankiteo, CHANGE BIOTEC LIMITED does not hold a SOC 2 Type 2 certification.

Does CHANGE BIOTEC LIMITED comply with GDPR ?

According to Rankiteo, CHANGE BIOTEC LIMITED is not listed as GDPR compliant.

Does CHANGE BIOTEC LIMITED have PCI DSS certification ?

According to Rankiteo, CHANGE BIOTEC LIMITED does not currently maintain PCI DSS compliance.

Does CHANGE BIOTEC LIMITED comply with HIPAA ?

According to Rankiteo, CHANGE BIOTEC LIMITED is not compliant with HIPAA regulations.

Does CHANGE BIOTEC LIMITED have ISO 27001 certification ?

According to Rankiteo,CHANGE BIOTEC LIMITED is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does CHANGE BIOTEC LIMITED operate in ?

CHANGE BIOTEC LIMITED operates primarily in the Biotechnology Research industry.

How many employees does CHANGE BIOTEC LIMITED have ?

CHANGE BIOTEC LIMITED employs approximately 8 people worldwide.

Does CHANGE BIOTEC LIMITED own any subsidiaries ?

CHANGE BIOTEC LIMITED presently has no subsidiaries across any sectors.

How many LinkedIn followers does CHANGE BIOTEC LIMITED have ?

CHANGE BIOTEC LIMITED's official LinkedIn profile has approximately 126,868 followers.

What is the NAICS classification code for CHANGE BIOTEC LIMITED ?

CHANGE BIOTEC LIMITED is classified under the NAICS code 541714, which corresponds to Research and Development in Biotechnology (except Nanobiotechnology).

Does CHANGE BIOTEC LIMITED have a Crunchbase profile ?

No, CHANGE BIOTEC LIMITED does not have a profile on Crunchbase.

Does CHANGE BIOTEC LIMITED have a LinkedIn profile ?

Yes, CHANGE BIOTEC LIMITED maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/change-biotec-limited.

How many cybersecurity incidents has CHANGE BIOTEC LIMITED experienced ?

As of June 27, 2026, Rankiteo reports that CHANGE BIOTEC LIMITED has not experienced any cybersecurity incidents.

How many peer or competitor companies does CHANGE BIOTEC LIMITED have ?

CHANGE BIOTEC LIMITED has an estimated 4,711 peer or competitor companies worldwide.

NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop

WindowsmacOSLinux

Download

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

CBL

Boost Score +25 with badge (5 left)

749

/1000

Moderate

774

/1000

Fair

CHANGE BIOTEC LIMITED Vendor Cyber Rating & Cyber Score

changebiotec.com

Add Your Compliance Badge

We are an African Biotech Company Based in Nairobi Kenya. We are focused on the supply of Life Science solutions to Research institutions, Biotech startups, Hospitals, and similar clients.

CBL A.I CyberSecurity Scoring

Scoring History

CBL

CHANGE BIOTEC LIMITED CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

No data available

Loading…

A.I.

CBL Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for CBL

Incidents vs Biotechnology Research Industry Avg (This Year)

No incidents recorded for CHANGE BIOTEC LIMITED in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for CHANGE BIOTEC LIMITED in 2026.

Incident Types CBL vs Biotechnology Research Industry Avg (This Year)

No incidents recorded for CHANGE BIOTEC LIMITED in 2026.

Incident History - CBL (X = Date, Y = Severity)

Loading…

SUBSIDIARY

CHANGE BIOTEC LIMITED Subsidiaries

Parent Company

CBL

Biotechnology Research

Website: www.changebiotec.com

Company Size: 8

No subsidiary data available for this company.

Loading…

CHANGE BIOTEC LIMITED Similar Companies

Charles River Laboratories

criver.com

At Charles River, we are guided by our strong purpose—to create healthier lives—which centers around the patients who rely on the therapeutics we help to develop, the animals in our care, to our planet, and to the passionate and skilled people who are at the heart of our organization and make it all possible. #DrugDiscovery #Biotech #Biotechnology #Pharmaceuticals #CRL

Avantor

cb avantorsciences.com

Avantor® is a leading global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. Our portfolio is used in virtually every stage of the most important research, development and production activities in the industries we serve. Our global footprint enables us to serve more than 300,000 customer locations and gives us extensive access to research laboratories and scientists in more than 180 countries. We set science in motion to create a better world. More than 14,500 strong, our associates are passionate about our mission to set science in motion to create a better world. We share enthusiasm for innovation, excellence, and achievement. Whether we are collaborating with our customers to advance science or solve multifaceted problems, we help them reach their goals more efficiently and effectively. Visit our website to learn more about Avantor.

CSL

cb csl.com

CSL is a leading global biopharma company with a dynamic portfolio of lifesaving medicines, including those that treat haemophilia and immune deficiencies, vaccines to prevent influenza, and therapies in iron deficiency, dialysis and nephrology. Since our start in 1916, we have been driven by our promise to save lives using the latest technologies. Today, CSL – including our businesses, CSL Behring, CSL Seqirus, and CSL Vifor – provides lifesaving products to patients in more than 100 countries and employs 29,000+ people. Our unique combination of commercial strength, R&D focus and operational excellence enables us to identify, develop and deliver innovations so our patients can live life to the fullest. See our community guidelines: https://bit.ly/3Bs17Ra

Eurofins

cb eurofins.com

Since 1987, Eurofins has grown from one laboratory in Nantes, France to over 65,000 staff across a network of independent companies in 60 countries, operating over 950 laboratories. Performing over 450 million tests every year, Eurofins offers a portfolio of over 200,000 analytical methods to evaluate the safety, identity, composition, authenticity, origin, traceability and purity of biological substances and products, as well as providing innovative clinical diagnostic testing services, as one of the leading global emerging players in specialised clinical diagnostics testing. Ever since its IPO on the French stock exchange in 1997, Eurofins has been one of the fastest growing listed European companies.

ICON plc

iconplc.com

Since our foundation in Dublin, Ireland in 1990, our mission has been to help our clients to accelerate the development of drugs and devices that save lives and improve quality of life. We do this by delivering best in class information, solutions and performance, with an unyielding focus on quality at all times. We offer a full range of consulting, development and commercialisation services from a global network of offices in 53 countries. We focus our innovation on the factors that are critical to our clients – reducing time to market, reducing cost, and increasing quality – and our global team of experts has extensive experience in a broad range of therapeutic areas.

Amgen

amgen.com

Amgen harnesses the best of biology and technology to fight the world’s toughest diseases, and make people’s lives easier, fuller and longer. We helped establish the biotechnology industry, and we remain on the cutting-edge of innovation, using technology and human genetic data to push beyond what’s known today. Our investment in research and development has yielded a robust pipeline that builds on our existing portfolio of medicines to treat cancer, heart disease, osteoporosis, inflammatory diseases and rare diseases. Amgen is one of 30 companies comprising the Dow Jones Industrial Average®, and part of the Nasdaq-100 Index®. In 2024, Amgen was named one of the “World’s Most Innovative Companies” by Fast Company and one of “America’s Best Large Employers” by Forbes. For more information, visit Amgen.com and follow us on X, LinkedIn, Instagram, TikTok, YouTube and Threads. 🔗 Community Guidelines: https://wwwext.amgen.com/community-guidelines 🔗Global Privacy Statement Directory: www.amgen.com/dp Special Advisory: Please be cautious of scam recruitment offers claiming to be from Amgen. Such scams may come from various sources, including fake websites and/or unsolicited emails and seek to obtain personal data or payment from victims by offering jobs that do not exist. Please be advised that Amgen would never ask for payment to progress a job application. When in doubt, please check to see if the position in question is posted on this website before applying. Additionally, please report any suspicious recruiting activity to https://complaint.ic3.gov/ and thank you for your assistance.

Thermo Fisher Scientific

thermofisher.com

About Thermo Fisher Scientific Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue of approximately $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit www.thermofisher.com.

Agilent Technologies

cb agilent.com

Agilent customers are finding new ways to treat cancer, ensure food, water, air, and medicine quality and safety, discover new drug treatments, research infectious diseases, and create alternative energy solutions for a greener planet. From start to finish, we have them covered with our vast product solutions and services portfolio. Around the world, Agilent’s people bring innovations, technologies, and services to the forefront of science. Our teams design and manufacture a wide array of advanced analytical, research, and diagnostic solutions and tools for use inside and outside laboratories. Additionally, the unique expertise of Agilent’s CrossLab and technical teams provides valuable insight and support to our customers, helping them fully optimize their laboratories and resources to better focus on what's important: bringing great science to life. In fiscal 2022, Agilent Technologies generated revenue of (US) $6.85 billion.

Roche

cb roche.com

Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. The company also aims to improve patient access to medical innovations by working with all relevant stakeholders. Thirty medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines. Roche has been recognised as the Group Leader in sustainability within the Pharmaceuticals, Biotechnology & Life Sciences Industry ten years in a row by the Dow Jones Sustainability Indices (DJSI). For more information, please visit https://careers.roche.com Read our community guidelines here: https://www.roche.com/some-guidelines.htm #Roche #Biotechnology #Pharmaceuticals #Diagnostics #Healthcare #PersonalisedHealthcare #GreatPlaceToWork #Innovation

Loading…

NEWS

CHANGE BIOTEC LIMITED CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

March 31, 2026 08:30 PM

HUB Cyber Security Ltd. Announces Board Changes, Effective March 31, 2026

HUB Cyber Security Ltd. announced that Noah Hershcoviz has resigned from his position as a member of the Company?s Board of Directors,...

Read Article

May 20, 2024 07:00 AM

New Biotech Platforms Offer Better Paths to Biosecurity

Changes in uses of digital technology improved cybersecurity, offering a blueprint for making biotechnology more secure.

Read Article

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-56414

SUMMARY

A vulnerability exists in H.View IP cameras certificate-related upload interfaces allow authenticated users to store arbitrary file content to fixed, persistent filesystem locations without validating file type, structure, or size. This design omission enables the placement of unexpected or malformed data in locations intended for trusted certificate material, which could affect system integrity or behavior even after reboot.

Published

Date2026-06-26

Updated

Date2026-06-26

RISK INFORMATION (Score: 7.2)

cvss3

Base Score: 7.2

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:H/UI:N/S:U/C:H/I:H/A:H

cvss4

Base Score: 8.6

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:H/UI:N/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

5.9

Exploitability

1.2

REFERENCES

CVE-2026-55975

SUMMARY

A vulnerability exists in H.View IP cameras that could allow an authenticated user to supply unsanitized XML fields to the device's certificate generation interface, which are incorporated into a backend certificate creation command without proper input validation. This may allow for command execution with elevated privileges during certificate generation.

Published

Date2026-06-26

Updated

Date2026-06-26

RISK INFORMATION (Score: 7.2)

cvss3

Base Score: 7.2

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:H/UI:N/S:U/C:H/I:H/A:H

cvss4

Base Score: 8.6

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:H/UI:N/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

5.9

Exploitability

1.2

REFERENCES

CVE-2026-33560

SUMMARY

The DMP-5000 file service exposes authenticated arbitrary file upload functionality. There are exposed endpoints which allows authenticated users to upload files of any type without validation. No file extension filtering or content inspection is enforced which allows executable binaries and scripts to be accepted and written directly to the server.

Published

Date2026-06-26

Updated

Date2026-06-26

RISK INFORMATION (Score: 7.1)

cvss3

Base Score: 7.1

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:H/A:N

cvss4

Base Score: 8.4

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:H/VA:N/SC:L/SI:H/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

4.2

Exploitability

2.8

REFERENCES

CVE-2026-31928

SUMMARY

The DMP-5000 devices are shipped with a default administrative web account with weak authentication controls, which are not required to be changed during initial configuration or operation. Using these accounts provides full system access.

Published

Date2026-06-26

Updated

Date2026-06-26

RISK INFORMATION (Score: 8.1)

cvss3

Base Score: 8.1

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:N

cvss4

Base Score: 9.3

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:H/VI:H/VA:N/SC:H/SI:H/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

5.2

Exploitability

2.8

REFERENCES

CVE-2026-28701

SUMMARY

Various versions of Daktronics Controller Firmware could allow authenticated and unauthenticated remote users to escape the intended directory and enumerate arbitrary file system paths.

Published

Date2026-06-26

Updated

Date2026-06-26

RISK INFORMATION (Score: 9.8)

cvss3

Base Score: 9.8

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H

cvss4

Base Score: 9.3

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

5.9

Exploitability

3.9

REFERENCES

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…